tirzepatide emerge 2nd Order From : r/tirzepatidecompound A Major GLP-1 Drug Shortage

Since GLP-1 RAs are primarily glucose-lowering medications, the benefits of selecting these agents should be weighed against the benefits of alternative diabetes control options

A report published last year from KFF, a nonprofit group that researches health policy issues, found that in 2021, people with employer-based health insurance who were overweight or had obesity had an average of $12,588 in total annual health costs, more than double the $4,699 in health spending for those who werent overweight or didnt have obesity

Howard Aubert who joined Pazona MD in 2024

This could also happen with Ozempic, Wegovy, and other weight loss injectables